Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other
companies in this sector in CHINA :
Heilongjiang ZBD Pharmaceutical Co Ltd
sales of 3.29 billion Chinese Renmimbi [US$461.34 million]
of which 62%
was Pharmaceutical Industry),
Guizhou Yibai Pharmaceutical Co., Ltd.
(3.36 billion Chinese Renmimbi [US$471.05 million]
of which 83%
was Medical Industry), and
Hengkang Medical Group Co Ltd
(3.68 billion Chinese Renmimbi [US$516.30 million]
of which 87%
was Medical service).
During the year ended December of 2019, sales at
Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 3.52 billion Chinese Renmimbi (US$493.98 million).
increase of 5.9%
versus 2018, when the company's sales were 3.33 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(and since 2014, sales have increased a total of 61%).
Sales of Medicine Retail Sales and Wholesales saw an increase
that was more than double the company's growth rate: sales were up
13.0% in 2019, from
1.52 billion Chinese Renmimbi to 1.72 billion Chinese Renmimbi.
Not all segments of Zhuzhou Qianjin Pharmaceutical Co., Ltd. experienced an increase in sales in 2019:
sales of Other fell 7.0% to 269.12 million Chinese Renmimbi.